Related Experiment Videos
Sphingolipid targets in cancer therapy
David E Modrak1, David V Gold, David M Goldenberg
1Garden State Cancer Center, Center for Molecular Medicine and Immunology, 520 Belleville Avenue, Belleville, NJ 07109, USA. dmodrak@gscancer.org
Molecular Cancer Therapeutics
|March 1, 2006
Summary
Ceramide, a key molecule in cancer cell death, can be manipulated to improve chemotherapy effectiveness. Targeting ceramide production or its pathways offers a promising strategy for enhancing cancer treatment outcomes.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Ceramide plays a crucial role as an intracellular second messenger in inducing apoptotic cell death.
- Cancer cells produce ceramide in response to radiation and chemotherapy, linking it to drug resistance.
Purpose of the Study:
- To review the sphingolipid biosynthetic pathway concerning ceramide.
- To identify potential drug discovery targets for modulating ceramide levels.
- To explore novel agents for enhancing chemotherapy efficacy.
Main Methods:
- Literature review of ceramide's role in apoptosis and cancer therapy.
- Analysis of the sphingolipid biosynthetic pathway.
- Identification of enzymes involved in ceramide production and utilization.
Main Results:
- Ceramide generation is central to apoptosis induction by cancer treatments.
- Pharmacological modulation of intracellular ceramide levels can impact drug resistance.
- Subcellular localization of ceramide production influences its biological activity.
Conclusions:
- Targeting enzymes in the sphingolipid pathway offers a strategy for drug discovery.
- Direct application of sphingolipids or enzyme inhibition/activation can alter ceramide levels.
- Understanding ceramide metabolism is vital for developing novel cancer therapeutics.